Low-Dose Oral Minoxidil Monitoring Questioned - Takeaways - MDSpire
From the Journals

Low-Dose Oral Minoxidil Monitoring Questioned

A retrospective hair clinic study found stable blood pressure, heart rate, weight, and laboratory measures during follow-up of up to 30 months.

  • By

  • Kathryn Wighton

  • May 14, 2026

  • 6 min

Share

  • 1

    Routine monitoring may not be necessary for asymptomatic patients on low-dose minoxidil.

  • 2

    Study included 74 female patients over 30 months.

  • 3

    Common adverse effects included hypertrichosis and dizziness.

  • 4

    Patients started on 0.625 mg, with potential increases based on tolerability.

  • 5

    Individualized monitoring is recommended for those with renal or cardiovascular concerns.

Original Source(s)

Low-Dose Oral Minoxidil Monitoring Questioned

  • by Kathryn Wighton

  • May 14, 2026

Related Content

Why FDA Said No to a Melanoma Drug

Questions over trial design and political pressure shadowed the rejection of Replimune’s RP1 treatment.

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

AOPT Plus Collagen May Ease Rosacea

Randomized trial suggests better short-term outcomes and lower recurrence at 24 weeks